OLIVIA CODY: Open Payments
NPI 1063101368 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 50 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $182 |
| Madrigal Pharmaceuticals | 20 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Aimmune Therapeutics, Inc. | 3 | $73 |
| Ardelyx, Inc. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| GENZYME CORPORATION | 1 | $40 |
| Janssen Biotech, Inc. | 1 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
Products named: REZDIFFRA, RINVOQ, DUPIXENT, ENTYVIO, ZENPEP, IBSRELA, TREMFYA, IQIRVO.
Industry payments across IN — which companies pay providers there.
